SCHEMBL16106909

SCHEMBL16106909

[O]C[C@H]1CNCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4691876 1.00
SCHEMBL197402 0.82
SCHEMBL3962185 0.81
SCHEMBL1746181 0.80 SLC6A2 (0.42)
SCHEMBL536771 0.80 SLC6A2 (0.42)
SCHEMBL3429880 0.79 SLC6A2 (0.40)
SCHEMBL14474333 0.77
SCHEMBL20878691 0.77
Iodide SCHEMBL5326404 0.77 SLC6A2 (0.38)
SCHEMBL6690283 0.77 SLC6A2 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2780026-B1 HCV NS3 PROTEASE INHIBITORS MERCK SHARP & DOHME (US) 2019-10-23 EP disclosed
US-9328138-B2 HCV NS3 protease inhibitors MSD ITALIA S.R.L. (IT) 2016-05-03 US disclosed
US-20140296136-A1 HCV NS3 PROTEASE INHIBITORS MERCK SHARP & DOHME LLC 2014-10-02 US disclosed